Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-24
1993-06-15
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3135
Patent
active
052198820
ABSTRACT:
A method is provided for treating human patients who have Lymes disease by using a psoralen compound, preferably administered in a dosage of 0.3 to 0.7 mg/kg, and activating same either in vitro or in vivo using electromagnetic radiation of a prescribed activating wavelength. The activation of the psoralen compound in the presence of a blood fraction from a patient suffering from Lymes disease produces a composition which will stimulate an effective immune response to the Lymes disease on the part of the patient.
REFERENCES:
patent: 4999375 (1991-03-01), Bachynsky et al.
Chemical Abstracts 95: 636y (1981).
Chemical Abstracts 114: 20282u (1991).
"Lyme Disease Vaccine May be Difficult to Develop Because of Immune Response to Vaccine Proteins", FDC Reports, The Blue Sheet, pp. 7-8, Jun. 10, 1992.
Bisaccia Emil
Klainer Albert S.
Cave Bryan
Schenkman Leonard
LandOfFree
Treatment methods for lymes disease and associated debilitating does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment methods for lymes disease and associated debilitating , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment methods for lymes disease and associated debilitating will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1043040